Dr. Anne Elizabeth Dixon, MD
Pulmonary Disease Physician in Burlington, VT
NPI: 1164431847Primary Practice Location
University of Vermont Medical Center Inc
111 Colchester Ave, Burlington, Vermont, 05401
HQ Phone
Get Dr. Dixon's Phone Numberphone_androidMobile
Get Dr. Dixon's MobileAbout Dr. Anne Elizabeth Dixon, MD
Technology Used by Dr. Anne Elizabeth Dixon, MD
Looking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Dr. Anne Elizabeth Dixon, MD Specialties
Dr. Anne Elizabeth Dixon, MD Certifications & Licensure
VT State Medical License
Dr. Anne Elizabeth Dixon, MD Education & Trainingkeyboard_arrow_up
Oxford University Medical School
ox.ac.uk
Medical School
Until 1990
Dr. Anne Elizabeth Dixon, MD Top 5 Procedures done in 2025keyboard_arrow_up
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 25 | 34 |
| 2 | 94010Measurement and graphic recording of total and timed exhaled air capacity | 20 | 26 |
Dr. Anne Elizabeth Dixon, MD Publications
Authors: Meredith McCormack, Fernando Holguin, Ross Summer, Irina Petrache, Deepa Rastogi, Kelan Tantisira, Benjamin Suratt
Fluctuation Analysis of Peak Expiratory Flow and Its Association with Treatment Failure in Asthma.
Authors: Robert Wise, Stephen Peters, David Kaminsky
Journal: Am J Respir Crit Care Med
Rhinosinusitis and asthma: the missing link.
Authors: @ValidYN, LastName, ForeName, Initials, AffiliationInfo
Journal: Curr Opin Pulm Med
Dr. Anne Elizabeth Dixon, MD Clinical Trials2 Clinical Trialskeyboard_arrow_up
Lead Sponsor: University of Vermont
Collaborators: Duke University
Intervention / Treatment: DRUG: Placebo oral tablet, DRUG: Mitoquinol
Lead Sponsor: Sanofi
Collaborators: Regeneron Pharmaceuticals
Intervention / Treatment: DRUG: Placebo, DRUG: Dupilumab, DRUG: Levalbuterol/Levosalbutamol, DRUG: Inhaled corticosteroid (ICS) therapy, DRUG: Albuterol/Salbutamol